Long-Term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients With Centrally Located Thoracic Tumors: SABR for Central Thoracic Tumors. Radiology and Oncology, v. 54, n. 4, p. 480–487, 13 Nov.2020.